カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の自己免疫疾患用Fc融合タンパク質市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Fc Fusion Protein for Autoimmune Disease Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19315）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19315
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の自己免疫疾患用Fc融合タンパク質市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

自己免疫疾患用Fc融合タンパク質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の自己免疫疾患用Fc融合タンパク質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

自己免疫疾患用Fc融合タンパク質市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・オレンシア、エンブレル

用途別セグメントは次のように区分されます。
・関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他

世界の自己免疫疾患用Fc融合タンパク質市場の主要な市場プレーヤーは以下のとおりです。
・Bristol-Myers Squibb、Amgen、Pfizer、3SBIO、Celgen Biopharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、自己免疫疾患用Fc融合タンパク質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な自己免疫疾患用Fc融合タンパク質メーカーの企業概要、2019年～2022年までの自己免疫疾患用Fc融合タンパク質の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な自己免疫疾患用Fc融合タンパク質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別自己免疫疾患用Fc融合タンパク質の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの自己免疫疾患用Fc融合タンパク質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での自己免疫疾患用Fc融合タンパク質市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および自己免疫疾患用Fc融合タンパク質の産業チェーンを掲載しています。
・第13、14、15章では、自己免疫疾患用Fc融合タンパク質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 自己免疫疾患用Fc融合タンパク質の概要
- 種類別分析（2017年vs2021年vs2028年）：オレンシア、エンブレル
- 用途別分析（2017年vs2021年vs2028年）：関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他
- 世界の自己免疫疾患用Fc融合タンパク質市場規模・予測
- 世界の自己免疫疾患用Fc融合タンパク質生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bristol-Myers Squibb、Amgen、Pfizer、3SBIO、Celgen Biopharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：オレンシア、エンブレル
・用途別分析2017年-2028年：関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他
・自己免疫疾患用Fc融合タンパク質の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・自己免疫疾患用Fc融合タンパク質のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・自己免疫疾患用Fc融合タンパク質のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・自己免疫疾患用Fc融合タンパク質の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・自己免疫疾患用Fc融合タンパク質の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Fc Fusion Protein for Autoimmune Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fc Fusion Protein for Autoimmune Disease market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Rheumatoid Arthritis accounting for % of the Fc Fusion Protein for Autoimmune Disease global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Orencia segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fc Fusion Protein for Autoimmune Disease include Bristol-Myers Squibb, Amgen, Pfizer, 3SBIO, and Celgen Biopharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fc Fusion Protein for Autoimmune Disease market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Orencia
Enbrel
Market segment by Application can be divided into
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other
The key market players for global Fc Fusion Protein for Autoimmune Disease market are listed below:
Bristol-Myers Squibb
Amgen
Pfizer
3SBIO
Celgen Biopharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fc Fusion Protein for Autoimmune Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fc Fusion Protein for Autoimmune Disease, with price, sales, revenue and global market share of Fc Fusion Protein for Autoimmune Disease from 2019 to 2022.
Chapter 3, the Fc Fusion Protein for Autoimmune Disease competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fc Fusion Protein for Autoimmune Disease breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fc Fusion Protein for Autoimmune Disease market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fc Fusion Protein for Autoimmune Disease.
Chapter 13, 14, and 15, to describe Fc Fusion Protein for Autoimmune Disease sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Fc Fusion Protein for Autoimmune Disease Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fc Fusion Protein for Autoimmune Disease Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Orencia
1.2.3 Enbrel
1.3 Market Analysis by Application
1.3.1 Overview: Global Fc Fusion Protein for Autoimmune Disease Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Juvenile Idiopathic Arthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Other
1.4 Global Fc Fusion Protein for Autoimmune Disease Market Size & Forecast
1.4.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume (2017-2028)
1.4.3 Global Fc Fusion Protein for Autoimmune Disease Price (2017-2028)
1.5 Global Fc Fusion Protein for Autoimmune Disease Production Capacity Analysis
1.5.1 Global Fc Fusion Protein for Autoimmune Disease Total Production Capacity (2017-2028)
1.5.2 Global Fc Fusion Protein for Autoimmune Disease Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fc Fusion Protein for Autoimmune Disease Market Drivers
1.6.2 Fc Fusion Protein for Autoimmune Disease Market Restraints
1.6.3 Fc Fusion Protein for Autoimmune Disease Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Product and Services
2.1.4 Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Fc Fusion Protein for Autoimmune Disease Product and Services
2.2.4 Amgen Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Fc Fusion Protein for Autoimmune Disease Product and Services
2.3.4 Pfizer Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 3SBIO
2.4.1 3SBIO Details
2.4.2 3SBIO Major Business
2.4.3 3SBIO Fc Fusion Protein for Autoimmune Disease Product and Services
2.4.4 3SBIO Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Celgen Biopharma
2.5.1 Celgen Biopharma Details
2.5.2 Celgen Biopharma Major Business
2.5.3 Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Product and Services
2.5.4 Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fc Fusion Protein for Autoimmune Disease Breakdown Data by Manufacturer
3.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fc Fusion Protein for Autoimmune Disease
3.4 Market Concentration Rate
3.4.1 Top 3 Fc Fusion Protein for Autoimmune Disease Manufacturer Market Share in 2021
3.4.2 Top 6 Fc Fusion Protein for Autoimmune Disease Manufacturer Market Share in 2021
3.5 Global Fc Fusion Protein for Autoimmune Disease Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fc Fusion Protein for Autoimmune Disease Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fc Fusion Protein for Autoimmune Disease Market Size by Region
4.1.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume by Region (2017-2028)
4.1.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Region (2017-2028)
4.2 North America Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
4.3 Europe Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
4.4 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
4.5 South America Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
4.6 Middle East and Africa Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume by Type (2017-2028)
5.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Type (2017-2028)
5.3 Global Fc Fusion Protein for Autoimmune Disease Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fc Fusion Protein for Autoimmune Disease Sales in Volume by Application (2017-2028)
6.2 Global Fc Fusion Protein for Autoimmune Disease Revenue by Application (2017-2028)
6.3 Global Fc Fusion Protein for Autoimmune Disease Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
7.2 North America Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
7.3 North America Fc Fusion Protein for Autoimmune Disease Market Size by Country
7.3.1 North America Fc Fusion Protein for Autoimmune Disease Sales in Volume by Country (2017-2028)
7.3.2 North America Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
8.2 Europe Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
8.3 Europe Fc Fusion Protein for Autoimmune Disease Market Size by Country
8.3.1 Europe Fc Fusion Protein for Autoimmune Disease Sales in Volume by Country (2017-2028)
8.3.2 Europe Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
9.2 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
9.3 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Market Size by Region
9.3.1 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fc Fusion Protein for Autoimmune Disease Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
10.2 South America Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
10.3 South America Fc Fusion Protein for Autoimmune Disease Market Size by Country
10.3.1 South America Fc Fusion Protein for Autoimmune Disease Sales in Volume by Country (2017-2028)
10.3.2 South America Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2028)
11.2 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2028)
11.3 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Market Size by Country
11.3.1 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fc Fusion Protein for Autoimmune Disease and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fc Fusion Protein for Autoimmune Disease
12.3 Fc Fusion Protein for Autoimmune Disease Production Process
12.4 Fc Fusion Protein for Autoimmune Disease Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fc Fusion Protein for Autoimmune Disease Typical Distributors
13.3 Fc Fusion Protein for Autoimmune Disease Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Fc Fusion Protein for Autoimmune Disease Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Fc Fusion Protein for Autoimmune Disease Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Product and Services
Table 6. Bristol-Myers Squibb Fc Fusion Protein for Autoimmune Disease Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Fc Fusion Protein for Autoimmune Disease Product and Services
Table 10. Amgen Fc Fusion Protein for Autoimmune Disease Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Fc Fusion Protein for Autoimmune Disease Product and Services
Table 14. Pfizer Fc Fusion Protein for Autoimmune Disease Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. 3SBIO Basic Information, Manufacturing Base and Competitors
Table 16. 3SBIO Major Business
Table 17. 3SBIO Fc Fusion Protein for Autoimmune Disease Product and Services
Table 18. 3SBIO Fc Fusion Protein for Autoimmune Disease Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Celgen Biopharma Basic Information, Manufacturing Base and Competitors
Table 20. Celgen Biopharma Major Business
Table 21. Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Product and Services
Table 22. Celgen Biopharma Fc Fusion Protein for Autoimmune Disease Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Fc Fusion Protein for Autoimmune Disease Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Fc Fusion Protein for Autoimmune Disease Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Fc Fusion Protein for Autoimmune Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Fc Fusion Protein for Autoimmune Disease Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Fc Fusion Protein for Autoimmune Disease Production Site of Key Manufacturer
Table 28. Fc Fusion Protein for Autoimmune Disease New Entrant and Capacity Expansion Plans
Table 29. Fc Fusion Protein for Autoimmune Disease Mergers & Acquisitions in the Past Five Years
Table 30. Global Fc Fusion Protein for Autoimmune Disease Sales by Region (2017-2022) & (K Units)
Table 31. Global Fc Fusion Protein for Autoimmune Disease Sales by Region (2023-2028) & (K Units)
Table 32. Global Fc Fusion Protein for Autoimmune Disease Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Fc Fusion Protein for Autoimmune Disease Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2022) & (K Units)
Table 35. Global Fc Fusion Protein for Autoimmune Disease Sales by Type (2023-2028) & (K Units)
Table 36. Global Fc Fusion Protein for Autoimmune Disease Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Fc Fusion Protein for Autoimmune Disease Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Fc Fusion Protein for Autoimmune Disease Price by Type (2017-2022) & (US$/Unit)
Table 39. Global Fc Fusion Protein for Autoimmune Disease Price by Type (2023-2028) & (US$/Unit)
Table 40. Global Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2022) & (K Units)
Table 41. Global Fc Fusion Protein for Autoimmune Disease Sales by Application (2023-2028) & (K Units)
Table 42. Global Fc Fusion Protein for Autoimmune Disease Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Fc Fusion Protein for Autoimmune Disease Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Fc Fusion Protein for Autoimmune Disease Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Fc Fusion Protein for Autoimmune Disease Price by Application (2023-2028) & (US$/Unit)
Table 46. North America Fc Fusion Protein for Autoimmune Disease Sales by Country (2017-2022) & (K Units)
Table 47. North America Fc Fusion Protein for Autoimmune Disease Sales by Country (2023-2028) & (K Units)
Table 48. North America Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Fc Fusion Protein for Autoimmune Disease Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2022) & (K Units)
Table 51. North America Fc Fusion Protein for Autoimmune Disease Sales by Type (2023-2028) & (K Units)
Table 52. North America Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2022) & (K Units)
Table 53. North America Fc Fusion Protein for Autoimmune Disease Sales by Application (2023-2028) & (K Units)
Table 54. Europe Fc Fusion Protein for Autoimmune Disease Sales by Country (2017-2022) & (K Units)
Table 55. Europe Fc Fusion Protein for Autoimmune Disease Sales by Country (2023-2028) & (K Units)
Table 56. Europe Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Fc Fusion Protein for Autoimmune Disease Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2022) & (K Units)
Table 59. Europe Fc Fusion Protein for Autoimmune Disease Sales by Type (2023-2028) & (K Units)
Table 60. Europe Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2022) & (K Units)
Table 61. Europe Fc Fusion Protein for Autoimmune Disease Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales by Application (2023-2028) & (K Units)
Table 70. South America Fc Fusion Protein for Autoimmune Disease Sales by Country (2017-2022) & (K Units)
Table 71. South America Fc Fusion Protein for Autoimmune Disease Sales by Country (2023-2028) & (K Units)
Table 72. South America Fc Fusion Protein for Autoimmune Disease Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Fc Fusion Protein for Autoimmune Disease Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2022) & (K Units)
Table 75. South America Fc Fusion Protein for Autoimmune Disease Sales by Type (2023-2028) & (K Units)
Table 76. South America Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2022) & (K Units)
Table 77. South America Fc Fusion Protein for Autoimmune Disease Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales by Application (2023-2028) & (K Units)
Table 86. Fc Fusion Protein for Autoimmune Disease Raw Material
Table 87. Key Manufacturers of Fc Fusion Protein for Autoimmune Disease Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Fc Fusion Protein for Autoimmune Disease Typical Distributors
Table 91. Fc Fusion Protein for Autoimmune Disease Typical Customers
List of Figures
Figure 1. Fc Fusion Protein for Autoimmune Disease Picture
Figure 2. Global Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Type in 2021
Figure 3. Orencia
Figure 4. Enbrel
Figure 5. Global Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Application in 2021
Figure 6. Rheumatoid Arthritis
Figure 7. Juvenile Idiopathic Arthritis
Figure 8. Psoriatic Arthritis
Figure 9. Ankylosing Spondylitis
Figure 10. Other
Figure 11. Global Fc Fusion Protein for Autoimmune Disease Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Fc Fusion Protein for Autoimmune Disease Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Fc Fusion Protein for Autoimmune Disease Sales (2017-2028) & (K Units)
Figure 14. Global Fc Fusion Protein for Autoimmune Disease Price (2017-2028) & (US$/Unit)
Figure 15. Global Fc Fusion Protein for Autoimmune Disease Production Capacity (2017-2028) & (K Units)
Figure 16. Global Fc Fusion Protein for Autoimmune Disease Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Fc Fusion Protein for Autoimmune Disease Market Drivers
Figure 18. Fc Fusion Protein for Autoimmune Disease Market Restraints
Figure 19. Fc Fusion Protein for Autoimmune Disease Market Trends
Figure 20. Global Fc Fusion Protein for Autoimmune Disease Sales Market Share by Manufacturer in 2021
Figure 21. Global Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Manufacturer in 2021
Figure 22. Fc Fusion Protein for Autoimmune Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Fc Fusion Protein for Autoimmune Disease Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Fc Fusion Protein for Autoimmune Disease Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Fc Fusion Protein for Autoimmune Disease Sales Market Share by Region (2017-2028)
Figure 26. Global Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Region (2017-2028)
Figure 27. North America Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028) & (USD Million)
Figure 28. Europe Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028) & (USD Million)
Figure 30. South America Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Revenue (2017-2028) & (USD Million)
Figure 32. Global Fc Fusion Protein for Autoimmune Disease Sales Market Share by Type (2017-2028)
Figure 33. Global Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Type (2017-2028)
Figure 34. Global Fc Fusion Protein for Autoimmune Disease Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Fc Fusion Protein for Autoimmune Disease Sales Market Share by Application (2017-2028)
Figure 36. Global Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Application (2017-2028)
Figure 37. Global Fc Fusion Protein for Autoimmune Disease Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Fc Fusion Protein for Autoimmune Disease Sales Market Share by Type (2017-2028)
Figure 39. North America Fc Fusion Protein for Autoimmune Disease Sales Market Share by Application (2017-2028)
Figure 40. North America Fc Fusion Protein for Autoimmune Disease Sales Market Share by Country (2017-2028)
Figure 41. North America Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Country (2017-2028)
Figure 42. United States Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Fc Fusion Protein for Autoimmune Disease Sales Market Share by Type (2017-2028)
Figure 46. Europe Fc Fusion Protein for Autoimmune Disease Sales Market Share by Application (2017-2028)
Figure 47. Europe Fc Fusion Protein for Autoimmune Disease Sales Market Share by Country (2017-2028)
Figure 48. Europe Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Country (2017-2028)
Figure 49. Germany Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Region (2017-2028)
Figure 58. China Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Fc Fusion Protein for Autoimmune Disease Sales Market Share by Type (2017-2028)
Figure 65. South America Fc Fusion Protein for Autoimmune Disease Sales Market Share by Application (2017-2028)
Figure 66. South America Fc Fusion Protein for Autoimmune Disease Sales Market Share by Country (2017-2028)
Figure 67. South America Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Fc Fusion Protein for Autoimmune Disease Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Fc Fusion Protein for Autoimmune Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Fc Fusion Protein for Autoimmune Disease in 2021
Figure 79. Manufacturing Process Analysis of Fc Fusion Protein for Autoimmune Disease
Figure 80. Fc Fusion Protein for Autoimmune Disease Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の糖尿病用Fc融合タンパク質市場2022年：市場規模予測（～2028年）
  • 世界の血友病用Fc融合タンパク質市場2022年：市場規模予測（～2028年）
  • 世界の眼疾患用Fc融合タンパク質市場2022年：市場規模予測（～2028年）
  • 自己免疫疾患におけるキナーゼ阻害剤の世界市場2023年：理学療法、外科、その他
  • 世界のハンセン病治療市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19315 )"世界の自己免疫疾患用Fc融合タンパク質市場2022年：市場規模予測（～2028年）" (英文：Global Fc Fusion Protein for Autoimmune Disease Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。